Yayın:
Tofacitinib treatment in recalcitrant jdm patients

Basit Görünüm
dc.contributor.authorCekiç, S.
dc.contributor.authorKarali, Y.
dc.contributor.authorÇiçek, F.
dc.contributor.authorKılıç, S. S.
dc.contributor.departmentTıp Fakültesi
dc.contributor.orcid0000-0002-9574-1842
dc.contributor.orcid0000-0001-7348-7081
dc.contributor.orcid0000-0001-8571-2581
dc.contributor.researcheridAAH-1658-2021
dc.contributor.researcheridL-1933-2017
dc.date.accessioned2024-07-08T10:42:48Z
dc.date.available2024-07-08T10:42:48Z
dc.date.issued2020-06-01
dc.description.abstractBu çalışma, 03 Haziran 2020 tarihleri arasında düzenlenen Annual European Congress of Rheumatology (EULAR)’da bildiri olarak sunulmuştur.
dc.identifier.doi10.1136/annrheumdis-2020-eular.6022
dc.identifier.endpage823
dc.identifier.issn0003-4967
dc.identifier.issueSupplement 1
dc.identifier.startpage822
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2020-eular.6022
dc.identifier.urihttps://hdl.handle.net/11452/43036
dc.identifier.volume79
dc.identifier.wos000555905002422
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.journalAnnals Of The Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectMEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Rheumatology
dc.titleTofacitinib treatment in recalcitrant jdm patients
dc.typeOther
dc.type.subtypeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi
local.indexed.atWOS

Dosyalar

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications